Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus

Abstract Background In this study, we investigated whether serum levels of advanced glycation end products (AGEs) independently correlated with relative muscle strength after adjustment for clinical variables including diabetic peripheral neuropathy in patients with type 2 diabetes. Relative muscle...

Full description

Bibliographic Details
Main Authors: Tsung-Hui Wu, Shiow-Chwen Tsai, Hsuan-Wei Lin, Chiao-Nan Chen, Chii-Min Hwu
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Endocrine Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12902-022-01035-1
_version_ 1811306298418921472
author Tsung-Hui Wu
Shiow-Chwen Tsai
Hsuan-Wei Lin
Chiao-Nan Chen
Chii-Min Hwu
author_facet Tsung-Hui Wu
Shiow-Chwen Tsai
Hsuan-Wei Lin
Chiao-Nan Chen
Chii-Min Hwu
author_sort Tsung-Hui Wu
collection DOAJ
description Abstract Background In this study, we investigated whether serum levels of advanced glycation end products (AGEs) independently correlated with relative muscle strength after adjustment for clinical variables including diabetic peripheral neuropathy in patients with type 2 diabetes. Relative muscle strength was defined as muscle strength (in decinewtons, dN) divided by total muscle mass (in kg). Methods We enrolled 152 ambulatory patients with type 2 diabetes. Each participant underwent measurements of muscle strength and total muscle mass. Serum levels of AGEs were determined. The Michigan Neuropathy Screening Instrument Physical Examination (MNSI-PE) was performed to assess diabetic peripheral neuropathy. Results The participants were divided into three groups on the basis of tertiles of serum AGEs levels. Significant differences were observed among the three groups in relative handgrip strength (71.03 ± 18.22, 63.17 ± 13.82, and 61.47 ± 13.95 dN/kg in the low-tertile, mid-tertile, and high-tertile groups, respectively, P = 0.005). The relative muscle strength of the ankle plantar flexors was higher in the low-tertile group than in the mid-tertile and high-tertile groups (107.60 ± 26.53, 94.97 ± 19.72, and 94.18 ± 16.09 dN/kg in the low-tertile, mid-tertile, and high-tertile groups, respectively, P = 0.002). After adjustment for MNSI-PE score and other clinical variables in partial correlation analysis, the correlations between serum levels of AGEs and the relative muscle strength of handgrip, ankle dorsiflexor, and ankle plantar flexor remained significant. Serum AGEs level was the only variable that remained significantly related to the relative muscle strength of handgrip, ankle dorsiflexor, and ankle plantar flexor when AGEs level, fasting plasma glucose, and glycated hemoglobin (HbA1c) were entered into multiple regression models simultaneously. Conclusions After adjustment for multiple factors including diabetic peripheral neuropathy, this study demonstrated that increased serum levels of AGEs were independently associated with decreased relative muscle strength in patients with type 2 diabetes. Compared with fasting plasma glucose and HbA1c, serum level of AGEs is more strongly associated with relative muscle strength.
first_indexed 2024-04-13T08:41:54Z
format Article
id doaj.art-2999c2c513cb470181f7462ca966cba5
institution Directory Open Access Journal
issn 1472-6823
language English
last_indexed 2024-04-13T08:41:54Z
publishDate 2022-05-01
publisher BMC
record_format Article
series BMC Endocrine Disorders
spelling doaj.art-2999c2c513cb470181f7462ca966cba52022-12-22T02:53:51ZengBMCBMC Endocrine Disorders1472-68232022-05-012211910.1186/s12902-022-01035-1Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitusTsung-Hui Wu0Shiow-Chwen Tsai1Hsuan-Wei Lin2Chiao-Nan Chen3Chii-Min Hwu4Section of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General HospitalInstitute of Sports Science, University of TaipeiSection of Endocrinology and Metabolism, Department of Internal Medicine, Taipei Veterans General HospitalDepartment of Physical Therapy and Assistive Technology, School of Biomedical Science and Engineering, National Yang Ming Chiao Tung UniversitySection of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General HospitalAbstract Background In this study, we investigated whether serum levels of advanced glycation end products (AGEs) independently correlated with relative muscle strength after adjustment for clinical variables including diabetic peripheral neuropathy in patients with type 2 diabetes. Relative muscle strength was defined as muscle strength (in decinewtons, dN) divided by total muscle mass (in kg). Methods We enrolled 152 ambulatory patients with type 2 diabetes. Each participant underwent measurements of muscle strength and total muscle mass. Serum levels of AGEs were determined. The Michigan Neuropathy Screening Instrument Physical Examination (MNSI-PE) was performed to assess diabetic peripheral neuropathy. Results The participants were divided into three groups on the basis of tertiles of serum AGEs levels. Significant differences were observed among the three groups in relative handgrip strength (71.03 ± 18.22, 63.17 ± 13.82, and 61.47 ± 13.95 dN/kg in the low-tertile, mid-tertile, and high-tertile groups, respectively, P = 0.005). The relative muscle strength of the ankle plantar flexors was higher in the low-tertile group than in the mid-tertile and high-tertile groups (107.60 ± 26.53, 94.97 ± 19.72, and 94.18 ± 16.09 dN/kg in the low-tertile, mid-tertile, and high-tertile groups, respectively, P = 0.002). After adjustment for MNSI-PE score and other clinical variables in partial correlation analysis, the correlations between serum levels of AGEs and the relative muscle strength of handgrip, ankle dorsiflexor, and ankle plantar flexor remained significant. Serum AGEs level was the only variable that remained significantly related to the relative muscle strength of handgrip, ankle dorsiflexor, and ankle plantar flexor when AGEs level, fasting plasma glucose, and glycated hemoglobin (HbA1c) were entered into multiple regression models simultaneously. Conclusions After adjustment for multiple factors including diabetic peripheral neuropathy, this study demonstrated that increased serum levels of AGEs were independently associated with decreased relative muscle strength in patients with type 2 diabetes. Compared with fasting plasma glucose and HbA1c, serum level of AGEs is more strongly associated with relative muscle strength.https://doi.org/10.1186/s12902-022-01035-1Advanced glycation end productsRelative muscle strengthDiabetic peripheral neuropathyType 2 diabetes mellitus
spellingShingle Tsung-Hui Wu
Shiow-Chwen Tsai
Hsuan-Wei Lin
Chiao-Nan Chen
Chii-Min Hwu
Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
BMC Endocrine Disorders
Advanced glycation end products
Relative muscle strength
Diabetic peripheral neuropathy
Type 2 diabetes mellitus
title Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
title_full Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
title_fullStr Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
title_full_unstemmed Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
title_short Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
title_sort increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
topic Advanced glycation end products
Relative muscle strength
Diabetic peripheral neuropathy
Type 2 diabetes mellitus
url https://doi.org/10.1186/s12902-022-01035-1
work_keys_str_mv AT tsunghuiwu increasedserumlevelsofadvancedglycationendproductsarenegativelyassociatedwithrelativemusclestrengthinpatientswithtype2diabetesmellitus
AT shiowchwentsai increasedserumlevelsofadvancedglycationendproductsarenegativelyassociatedwithrelativemusclestrengthinpatientswithtype2diabetesmellitus
AT hsuanweilin increasedserumlevelsofadvancedglycationendproductsarenegativelyassociatedwithrelativemusclestrengthinpatientswithtype2diabetesmellitus
AT chiaonanchen increasedserumlevelsofadvancedglycationendproductsarenegativelyassociatedwithrelativemusclestrengthinpatientswithtype2diabetesmellitus
AT chiiminhwu increasedserumlevelsofadvancedglycationendproductsarenegativelyassociatedwithrelativemusclestrengthinpatientswithtype2diabetesmellitus